Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Heron Receives FDA Extension of NDA Review Period for Postoperative Pain Treatment

americanpharmaceuticalreviewMarch 09, 2020

Tag: Heron Therapeutics , NDA , HTX-011

PharmaSources Customer Service